Trials / Conditions / Core Binding Factor Acute Myeloid Leukemia
Core Binding Factor Acute Myeloid Leukemia
5 registered clinical trials studyying Core Binding Factor Acute Myeloid Leukemia — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Da NCT06917911 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation NCT06316960 | Children's Hospital of Soochow University | Phase 2 |
| Unknown | Avapritinib in CBF-AML With KIT Mutations NCT05821738 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Unknown | Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AML NCT05404516 | Nanfang Hospital, Southern Medical University | Phase 2 |
| Completed | Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT01238211 | National Cancer Institute (NCI) | Phase 2 |